Adverse Event (AE) Management With Pomalidomide (POM)+ Low-Dose Dexamethasone (LoDEX) in the STRATUS (TM) Trial: A Phase 3b Study Evaluating Safety and Efficacy in Patients (Pts) With Refractory or Relapsed and Refractory Multiple Myeloma (RRMM)
Adverse Event (AE) Management With Pomalidomide (POM)+ Low-Dose Dexamethasone (LoDEX) in the STRATUS (TM) Trial: A Phase 3b Study Evaluating Safety and Efficacy in Patients (Pts) With Refractory or Relapsed and Refractory Multiple Myeloma (RRMM)
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2015
Συγγραφείς:
Cavo, M Dimopoulos, MA Moreau, P Palumbo, A Corradini, P Weisel, K Ocio, E Doyen, C Anttila, P Raymakers, R others
